CANOSS_Freeze Dried Cancellous Bone
80 : CANOSS™: FDBA of cancellous bone. Preserves growth factors for superior osteoconduction and osteoinduction
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- CANOSS™
- Payment Terms
- T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Dental Consumables , Other Medical Consumables
HANS BIOMED CORP.
- Membership
- VIP
- Recent Visit
- Nov 26, 2024
- Country / Year Established
-
South Korea
/
1999
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | CANOSS_Freeze Dried Cancellous Bone | Certification | - |
|---|---|---|---|
| Category |
Dental Consumables
Other Medical Consumables |
Material | - |
| Keyword | freeze dried bone allograft , cancellous bone , bone powder , bone chip | Unit Size | - |
| Brand name | CANOSS™ | Unit Weigh | - |
| origin | South Korea | Stock | 1 |
| Supply type | Available | HS code | - |
Product Information
CANOSS™ is a freeze-dried bone allograft (FDBA) made from cancellous bone.
This non-demineralized allograft preserves growth factors and minerals,
enhancing osteoconduction and osteoinduction.
Its open trabecular structure, rich in minerals and collagen, promotes cell attachment and bone remodeling.
CANOSS™ creates an ideal environment for rapid revascularization and remodeling,
facilitating the formation of healthy autogenous bone.
The product's unique structure and composition make it highly effective for various dental bone grafting procedures,
offering excellent biocompatibility and ease of use.
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Express,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- HWANG, HO-CHAN
- Address
- Chongyi-ro 8 gil 7, Songpa-gu, Seoul, Korea
- Product Category
- Medical Consumables,Medical Devices
- Year Established
- 1999
- No. of Total Employees
- 101-500
- Company introduction
-
HansBiomed Corporation, established in 1999, is a global leader in tissue engineering and medical devices,
focusing on innovative aesthetic solutions.
Present in over 100 countries, HansBiomed has become a trusted partner in the aesthetic industry.
As a pioneer in the field, the company established Korea's first tissue bank in 2005 and is FDA-registered.
With a strong emphasis on R&D and innovation, HansBiomed has achieved consistent growth,
operating globally and exporting high-quality tissue transplants and medical products worldwide.
- Main Markets
-
China
Colombia
Russia
U.S.A
- Main Product
- Attached File
